Long-term safety outcomes of eliglustat in patients with Gaucher disease: Prospective, multi-center, observational, post authorization safety sub-registry study

被引：0
|
作者：
Giraldo, Pilar [1 ]
Batsu, Isabela [2 ]
Accomando, Beverly [3 ]
Gaemers, Sebastiaan J. M. [4 ]
Cil, Sefika Uslu [3 ]
Gouyette, Najat [5 ]
Scarpa, Maurizio [6 ]
机构：
[1] Hosp Quironsalud, Zaragoza, Spain
[2] Sanofi Genzyme, Bridgewater, NJ USA
[3] Sanofi, Cambridge, MA USA
[4] Sanofi, Amsterdam, Netherlands
[5] Capgemini Behalf Sanofi, Chilly Mazarin, France
[6] Univ Hosp Udine, Udine, Italy
来源：
MOLECULAR GENETICS AND METABOLISM | 2024年 / 141卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2023.107844
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
105
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Long-term safety and efficacy of agalsidase beta in Japanese patients with Fabry disease: aggregate data from two post-authorization safety studies
    Tsurumi, Mina
    Suzuki, Shinya
    Hokugo, Jiro
    Ueda, Kazuo
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (05) : 589 - 601
  • [32] The SkybriGHt registry study: A US multi-center, prospective, non-interventional, long-term, effectiveness and safety study of children and adolescents with growth hormone deficiency treated with lonapegsomatropin-tcgd
    Sather, Mako
    Brady, Meredith
    JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2024, 77 : 247 - 248
  • [33] Safety and Efficacy of Tolcapone in the Long-term Use in Parkinson Disease: An Observational Study
    Eggert, Karla
    Oertel, Wolfgang H.
    Lees, Andrew J.
    CLINICAL NEUROPHARMACOLOGY, 2014, 37 (01) : 1 - 5
  • [34] Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study
    Hidalgo, Olga Benitez
    Alonso, Cristina Marzo
    Jaime, Francisco Jose Lopez
    Carrasco, Marina
    Hernandez, Maria del Mar Nieto
    Afonso, Natalia
    Lei, Alejhandra
    Whyms, Dermot
    Hanna, Kim
    Aragones, Maria Esperanca
    Torres, Mireia
    Oliveras, Juan
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2025, 31
  • [35] Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study
    Lugogo, Njira
    Domingo, Christian
    Chanez, Pascal
    Leigh, Richard
    Gilson, Martyn J.
    Price, Robert G.
    Yancey, Steven W.
    Ortega, Hector G.
    CLINICAL THERAPEUTICS, 2016, 38 (09) : 2058 - 2070
  • [36] Evaluation of the long-term safety of cladribine tablets in multiple sclerosis: design of PREMIERE, a prospective, observational 8-year safety registry
    Miret, M.
    Weiner, J.
    Gedney, L.
    Greenberg, S.
    Alteri, E.
    JOURNAL OF NEUROLOGY, 2010, 257 : S144 - S144
  • [37] Long-Term Effectiveness and Safety of Infliximab, Golimumab and Golimumab-IV in Rheumatoid Arthritis Patients from a Prospective Observational Registry
    Rahman, Proton
    Baer, Philip
    Choquette, Denis
    Olszynski, Wojciech
    Faraawi, Rafat
    Bessette, Louis
    Baker, Milton
    Rai, Raman
    Kelsall, John
    Lisnevskaia, Larissa
    Reis, Jodie
    Anderson, Keltie
    Rampakakis, Emmanouil
    Rachich, Meagan
    Asin-Milan, Odalis
    Lehman, Allen
    Nantel, Francois
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [38] Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry
    Cappellini, Maria Domenica
    Carubbi, Francesca
    Di Rocco, Maja
    Giona, Fiorina
    Giuffrida, Gaetano
    BLOOD CELLS MOLECULES AND DISEASES, 2023, 98
  • [39] Prospective multi-center national study to standardize the follow-up of type 1 Gaucher disease patients treated with eliglustat under standard of care practice: TRAZELGA project
    Andrade-Campos, Marcio M.
    Cebolla, Jorge J.
    Lopez de Frutos, Laura
    Irun, Pilar
    Soledad Noya, Maria
    Nieto, S.
    Villalon, Lucia
    Arribas, A. I.
    Barez, Abelardo
    Garcia-Frade, Javier
    Hermosin, N.
    Hernandez Rivas, Jose Maria
    Ibarretxe, Daiana
    Lozano Almela, M. L.
    Molero, Maria T.
    Morado, M.
    Perez Saenz, M. A.
    Villarrubia, Jesus
    Giraldo, Pilar
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S22 - S23
  • [40] Long-term Safety of Facilitated Subcutaneous Immunoglobulin Treatment in Patients With Primary Immunodeficiency Diseases: Interim Analysis from a Post-authorization Safety Study
    Rubinstein, Arye
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB73 - AB73
12345